Claritev Corporation (NYSE: CTEV) Stock Competitors & Peer Comparison
See CTEV's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CTEV and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CTEV | $35.32 | +3.67% | 596M | -2.06 | -$17.01 | N/A |
| GEHC | $72.28 | -0.65% | 32.6B | 15.85 | $4.56 | +0.19% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $59.68 | +3.09% | 11.7B | 48.13 | $1.24 | N/A |
| TEM | $54.61 | -1.94% | 9.6B | -109.22 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $105.50 | -0.07% | 8.8B | 24.65 | $4.28 | N/A |
| TXG | $57.75 | -1.25% | 7.3B | -339.71 | -$0.17 | N/A |
| HNGE | $86.32 | -3.02% | 6.7B | 46.19 | $1.87 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
CTEV vs GEHC Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, GEHC has a market cap of 32.6B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while GEHC trades at $72.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas GEHC's P/E ratio is 15.85. In terms of profitability, CTEV's ROE is +1.40%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, CTEV is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
CTEV vs GEHCV Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas GEHCV's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, CTEV is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
CTEV vs BTSG Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, BTSG has a market cap of 11.7B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while BTSG trades at $59.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas BTSG's P/E ratio is 48.13. In terms of profitability, CTEV's ROE is +1.40%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, CTEV is less volatile compared to BTSG. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check BTSG's competition here
Tempus AI, Inc. (NASDAQ: TEM)
CTEV vs TEM Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, TEM has a market cap of 9.6B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while TEM trades at $54.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas TEM's P/E ratio is -109.22. In terms of profitability, CTEV's ROE is +1.40%, compared to TEM's ROE of -0.55%. Regarding short-term risk, CTEV is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
CTEV vs SGFY Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas SGFY's P/E ratio is 70.91. In terms of profitability, CTEV's ROE is +1.40%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, CTEV is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
CTEV vs HQY Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, HQY has a market cap of 8.8B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while HQY trades at $105.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas HQY's P/E ratio is 24.65. In terms of profitability, CTEV's ROE is +1.40%, compared to HQY's ROE of +0.11%. Regarding short-term risk, CTEV is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check HQY's competition here
10x Genomics, Inc. (NASDAQ: TXG)
CTEV vs TXG Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, TXG has a market cap of 7.3B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while TXG trades at $57.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas TXG's P/E ratio is -339.71. In terms of profitability, CTEV's ROE is +1.40%, compared to TXG's ROE of -0.09%. Regarding short-term risk, CTEV is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check TXG's competition here
Hinge Health, Inc. (NYSE: HNGE)
CTEV vs HNGE Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, HNGE has a market cap of 6.7B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while HNGE trades at $86.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas HNGE's P/E ratio is 46.19. In terms of profitability, CTEV's ROE is +1.40%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, CTEV is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
CTEV vs RCM Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas RCM's P/E ratio is -102.21. In terms of profitability, CTEV's ROE is +1.40%, compared to RCM's ROE of +0.00%. Regarding short-term risk, CTEV is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check RCM's competition here
Waystar Holding Corp. (NASDAQ: WAY)
CTEV vs WAY Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, WAY has a market cap of 4.7B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while WAY trades at $24.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas WAY's P/E ratio is 16.25. In terms of profitability, CTEV's ROE is +1.40%, compared to WAY's ROE of +0.04%. Regarding short-term risk, CTEV is less volatile compared to WAY. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check WAY's competition here
Doximity, Inc. (NYSE: DOCS)
CTEV vs DOCS Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, DOCS has a market cap of 4.7B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while DOCS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas DOCS's P/E ratio is 16.33. In terms of profitability, CTEV's ROE is +1.40%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, CTEV is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
CTEV vs ONEM Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas ONEM's P/E ratio is -7.77. In terms of profitability, CTEV's ROE is +1.40%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, CTEV is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
CTEV vs PRVA Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, PRVA has a market cap of 2.7B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while PRVA trades at $21.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas PRVA's P/E ratio is 102.57. In terms of profitability, CTEV's ROE is +1.40%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, CTEV is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check PRVA's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
CTEV vs HTFL Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, HTFL has a market cap of 2.6B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while HTFL trades at $29.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas HTFL's P/E ratio is -14.85. In terms of profitability, CTEV's ROE is +1.40%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, CTEV is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
CTEV vs WGS Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, WGS has a market cap of 2.5B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while WGS trades at $82.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas WGS's P/E ratio is 228.86. In terms of profitability, CTEV's ROE is +1.40%, compared to WGS's ROE of -0.39%. Regarding short-term risk, CTEV is more volatile compared to WGS. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check WGS's competition here
Progyny, Inc. (NASDAQ: PGNY)
CTEV vs PGNY Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, PGNY has a market cap of 2B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while PGNY trades at $25.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas PGNY's P/E ratio is 18.42. In terms of profitability, CTEV's ROE is +1.40%, compared to PGNY's ROE of +0.16%. Regarding short-term risk, CTEV is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check PGNY's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
CTEV vs NXGN Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas NXGN's P/E ratio is -266.00. In terms of profitability, CTEV's ROE is +1.40%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, CTEV is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check NXGN's competition here
Omada Health (NASDAQ: OMDA)
CTEV vs OMDA Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while OMDA trades at $23.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas OMDA's P/E ratio is 340.57. In terms of profitability, CTEV's ROE is +1.40%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, CTEV is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
CTEV vs AGTI Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas AGTI's P/E ratio is -71.79. In terms of profitability, CTEV's ROE is +1.40%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, CTEV is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check AGTI's competition here
Certara, Inc. (NASDAQ: CERT)
CTEV vs CERT Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, CERT has a market cap of 1.2B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while CERT trades at $8.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas CERT's P/E ratio is 20.02. In terms of profitability, CTEV's ROE is +1.40%, compared to CERT's ROE of -0.07%. Regarding short-term risk, CTEV is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
CTEV vs GDRX Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while GDRX trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas GDRX's P/E ratio is 11.22. In terms of profitability, CTEV's ROE is +1.40%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, CTEV is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check GDRX's competition here
Teladoc Health, Inc. (NYSE: TDOC)
CTEV vs TDOC Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, TDOC has a market cap of 1.2B. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while TDOC trades at $6.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas TDOC's P/E ratio is -7.44. In terms of profitability, CTEV's ROE is +1.40%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, CTEV is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check TDOC's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
CTEV vs CCLDO Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas CCLDO's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, CTEV is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
CTEV vs HSTM Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, HSTM has a market cap of 828.5M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while HSTM trades at $28.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas HSTM's P/E ratio is 35.01. In terms of profitability, CTEV's ROE is +1.40%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, CTEV is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check HSTM's competition here
Phreesia, Inc. (NYSE: PHR)
CTEV vs PHR Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, PHR has a market cap of 757.8M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while PHR trades at $12.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas PHR's P/E ratio is 43.79. In terms of profitability, CTEV's ROE is +1.40%, compared to PHR's ROE of +0.03%. Regarding short-term risk, CTEV is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check PHR's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
CTEV vs SOPH Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, SOPH has a market cap of 635.1M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while SOPH trades at $7.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas SOPH's P/E ratio is -6.82. In terms of profitability, CTEV's ROE is +1.40%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, CTEV is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check SOPH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
CTEV vs MPLN-WT Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, CTEV is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
CTEV vs ACCD Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas ACCD's P/E ratio is -3.08. In terms of profitability, CTEV's ROE is +1.40%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, CTEV is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
CTEV vs SHCR Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas SHCR's P/E ratio is -3.76. In terms of profitability, CTEV's ROE is +1.40%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, CTEV is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
CTEV vs EVH Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, EVH has a market cap of 469.6M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while EVH trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas EVH's P/E ratio is 32.12. In terms of profitability, CTEV's ROE is +1.40%, compared to EVH's ROE of -0.99%. Regarding short-term risk, CTEV is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check EVH's competition here
NRC Health (NASDAQ: NRC)
CTEV vs NRC Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, NRC has a market cap of 464.5M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while NRC trades at $20.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas NRC's P/E ratio is 25.13. In terms of profitability, CTEV's ROE is +1.40%, compared to NRC's ROE of +0.48%. Regarding short-term risk, CTEV is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check NRC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
CTEV vs SLGCW Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, CTEV's ROE is +1.40%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, CTEV is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check SLGCW's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
CTEV vs SLGC Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas SLGC's P/E ratio is -3.04. In terms of profitability, CTEV's ROE is +1.40%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, CTEV is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check SLGC's competition here
TruBridge, Inc. (NASDAQ: TBRG)
CTEV vs TBRG Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas TBRG's P/E ratio is 9.37. In terms of profitability, CTEV's ROE is +1.40%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, CTEV is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
CTEV vs MPLN Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas MPLN's P/E ratio is -0.23. In terms of profitability, CTEV's ROE is +1.40%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, CTEV is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check MPLN's competition here
So-Young International Inc. (NASDAQ: SY)
CTEV vs SY Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, SY has a market cap of 295.2M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while SY trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas SY's P/E ratio is -6.82. In terms of profitability, CTEV's ROE is +1.40%, compared to SY's ROE of -0.16%. Regarding short-term risk, CTEV is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check SY's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
CTEV vs TRHC Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas TRHC's P/E ratio is -4.27. In terms of profitability, CTEV's ROE is +1.40%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, CTEV is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
CTEV vs SMFR Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas SMFR's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, CTEV is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
CTEV vs SPOK Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, SPOK has a market cap of 229.3M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while SPOK trades at $10.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas SPOK's P/E ratio is 18.30. In terms of profitability, CTEV's ROE is +1.40%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, CTEV is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
CTEV vs AMWL Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, AMWL has a market cap of 214.8M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while AMWL trades at $12.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas AMWL's P/E ratio is -2.86. In terms of profitability, CTEV's ROE is +1.40%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, CTEV is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check AMWL's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
CTEV vs CPSI Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas CPSI's P/E ratio is -183.80. In terms of profitability, CTEV's ROE is +1.40%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, CTEV is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check CPSI's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
CTEV vs HCAT Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, HCAT has a market cap of 132.3M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while HCAT trades at $1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas HCAT's P/E ratio is 8.95. In terms of profitability, CTEV's ROE is +1.40%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, CTEV is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check HCAT's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
CTEV vs OPRX Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, OPRX has a market cap of 132.1M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while OPRX trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas OPRX's P/E ratio is 6.46. In terms of profitability, CTEV's ROE is +1.40%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, CTEV is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
CTEV vs AUGX Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas AUGX's P/E ratio is -4.99. In terms of profitability, CTEV's ROE is +1.40%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, CTEV is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
CTEV vs CCLD Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, CCLD has a market cap of 104.1M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while CCLD trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas CCLD's P/E ratio is 9.42. In terms of profitability, CTEV's ROE is +1.40%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, CTEV is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CCLD's competition here
SCWorx Corp. (NASDAQ: WORX)
CTEV vs WORX Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, WORX has a market cap of 88M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while WORX trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas WORX's P/E ratio is -6.40. In terms of profitability, CTEV's ROE is +1.40%, compared to WORX's ROE of -0.65%. Regarding short-term risk, CTEV is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check WORX's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
CTEV vs DH Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, DH has a market cap of 68.6M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while DH trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas DH's P/E ratio is 2.50. In terms of profitability, CTEV's ROE is +1.40%, compared to DH's ROE of -0.75%. Regarding short-term risk, CTEV is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
CTEV vs FORA Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas FORA's P/E ratio is -24.11. In terms of profitability, CTEV's ROE is +1.40%, compared to FORA's ROE of -0.17%. Regarding short-term risk, CTEV is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
CTEV vs CCLDP Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas CCLDP's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, CTEV is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
CTEV vs ONMD Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, ONMD has a market cap of 42.1M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while ONMD trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas ONMD's P/E ratio is -4.92. In terms of profitability, CTEV's ROE is +1.40%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, CTEV is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
CTEV vs SNCE Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas SNCE's P/E ratio is -0.27. In terms of profitability, CTEV's ROE is +1.40%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, CTEV is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
CTEV vs AKLI Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas AKLI's P/E ratio is -0.71. In terms of profitability, CTEV's ROE is +1.40%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, CTEV is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
CTEV vs SHLT Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas SHLT's P/E ratio is -3.87. In terms of profitability, CTEV's ROE is +1.40%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, CTEV is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
CTEV vs SHCRW Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, CTEV's ROE is +1.40%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, CTEV is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
CTEV vs ONMDW Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, ONMDW has a market cap of 32M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while ONMDW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas ONMDW's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, CTEV is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
CTEV vs STRM Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas STRM's P/E ratio is -2.40. In terms of profitability, CTEV's ROE is +1.40%, compared to STRM's ROE of -0.65%. Regarding short-term risk, CTEV is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
CTEV vs RNLX Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas RNLX's P/E ratio is -0.33. In terms of profitability, CTEV's ROE is +1.40%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, CTEV is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
CTEV vs LIFW Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas LIFW's P/E ratio is -0.02. In terms of profitability, CTEV's ROE is +1.40%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, CTEV is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check LIFW's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
CTEV vs SCNX Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, SCNX has a market cap of 17.8M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while SCNX trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas SCNX's P/E ratio is -0.17. In terms of profitability, CTEV's ROE is +1.40%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, CTEV is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check SCNX's competition here
Babylon Holdings Limited (NYSE: BBLN)
CTEV vs BBLN Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas BBLN's P/E ratio is -0.04. In terms of profitability, CTEV's ROE is +1.40%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, CTEV is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check BBLN's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
CTEV vs BEATW Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, BEATW has a market cap of 13M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while BEATW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas BEATW's P/E ratio is -0.03. In terms of profitability, CTEV's ROE is +1.40%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, CTEV is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check BEATW's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
CTEV vs BFRG Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, BFRG has a market cap of 10.8M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while BFRG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas BFRG's P/E ratio is -1.07. In terms of profitability, CTEV's ROE is +1.40%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, CTEV is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check BFRG's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
CTEV vs ETAO Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas ETAO's P/E ratio is -0.01. In terms of profitability, CTEV's ROE is +1.40%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, CTEV is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check ETAO's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
CTEV vs MGRX Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, MGRX has a market cap of 9M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while MGRX trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas MGRX's P/E ratio is -0.39. In terms of profitability, CTEV's ROE is +1.40%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, CTEV is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check MGRX's competition here
UpHealth, Inc. (NYSE: UPH)
CTEV vs UPH Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas UPH's P/E ratio is -0.07. In terms of profitability, CTEV's ROE is +1.40%, compared to UPH's ROE of -1.05%. Regarding short-term risk, CTEV is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
CTEV vs UPH-WT Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, CTEV is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check UPH-WT's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
CTEV vs PEAR Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas PEAR's P/E ratio is -0.08. In terms of profitability, CTEV's ROE is +1.40%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, CTEV is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
CTEV vs PEARW Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas PEARW's P/E ratio is -0.00. In terms of profitability, CTEV's ROE is +1.40%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, CTEV is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
CTEV vs OTRK Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas OTRK's P/E ratio is -0.02. In terms of profitability, CTEV's ROE is +1.40%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, CTEV is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check OTRK's competition here
CareMax, Inc. (NASDAQ: CMAX)
CTEV vs CMAX Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas CMAX's P/E ratio is -0.00. In terms of profitability, CTEV's ROE is +1.40%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, CTEV is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CMAX's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
CTEV vs HCTI Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, HCTI has a market cap of 1.4M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while HCTI trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas HCTI's P/E ratio is -0.16. In terms of profitability, CTEV's ROE is +1.40%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, CTEV is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check HCTI's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
CTEV vs VSEEW Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, VSEEW has a market cap of 1.4M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, CTEV's ROE is +1.40%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, CTEV is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
CTEV vs LIFWZ Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, CTEV is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check LIFWZ's competition here
Aclarion, Inc. (NASDAQ: ACON)
CTEV vs ACON Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, ACON has a market cap of 1.2M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while ACON trades at $2.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas ACON's P/E ratio is -0.25. In terms of profitability, CTEV's ROE is +1.40%, compared to ACON's ROE of -0.59%. Regarding short-term risk, CTEV is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check ACON's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
CTEV vs EUDAW Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas EUDAW's P/E ratio is 0.04. In terms of profitability, CTEV's ROE is +1.40%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, CTEV is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check EUDAW's competition here
VSee Health, Inc. (NASDAQ: VSEE)
CTEV vs VSEE Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, VSEE has a market cap of 816.5K. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while VSEE trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas VSEE's P/E ratio is -0.10. In terms of profitability, CTEV's ROE is +1.40%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, CTEV is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check VSEE's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
CTEV vs MSPRZ Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, CTEV is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
CTEV vs KERN Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas KERN's P/E ratio is -0.01. In terms of profitability, CTEV's ROE is +1.40%, compared to KERN's ROE of -0.20%. Regarding short-term risk, CTEV is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
CTEV vs KERNW Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas KERNW's P/E ratio is -0.00. In terms of profitability, CTEV's ROE is +1.40%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, CTEV is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
CTEV vs LIFWW Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas LIFWW's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, CTEV is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
CTEV vs ZCMD Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, ZCMD has a market cap of 37.2K. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while ZCMD trades at $1.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas ZCMD's P/E ratio is -0.04. In terms of profitability, CTEV's ROE is +1.40%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, CTEV is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
CTEV vs CMAXW Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas CMAXW's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, CTEV is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
CTEV vs ACONW Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, ACONW has a market cap of 13.1K. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas ACONW's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, CTEV is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check ACONW's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
CTEV vs WGSWW Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, WGSWW has a market cap of 5.8K. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas WGSWW's P/E ratio is -0.00. In terms of profitability, CTEV's ROE is +1.40%, compared to WGSWW's ROE of -0.39%. Regarding short-term risk, CTEV is more volatile compared to WGSWW. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check WGSWW's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
CTEV vs MTBCO Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas MTBCO's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, CTEV is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check MTBCO's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
CTEV vs MSPRV Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas MSPRV's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to MSPRV's ROE of N/A. Regarding short-term risk, CTEV is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check MSPRV's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
CTEV vs CNVY Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas CNVY's P/E ratio is -71.50. In terms of profitability, CTEV's ROE is +1.40%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, CTEV is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CNVY's competition here
Cerner Corporation (NASDAQ: CERN)
CTEV vs CERN Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, CERN has a market cap of 0. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas CERN's P/E ratio is 55.84. In terms of profitability, CTEV's ROE is +1.40%, compared to CERN's ROE of +0.14%. Regarding short-term risk, CTEV is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CERN's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
CTEV vs KURIU Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, KURIU has a market cap of 0. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas KURIU's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, CTEV is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check KURIU's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
CTEV vs SMFRW Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas SMFRW's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, CTEV is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check SMFRW's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
CTEV vs MTBCP Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas MTBCP's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, CTEV is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check MTBCP's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
CTEV vs IMS Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, IMS has a market cap of 0. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas IMS's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to IMS's ROE of +0.27%. Regarding short-term risk, CTEV is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check IMS's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
CTEV vs AFFX Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, AFFX has a market cap of 0. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas AFFX's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, CTEV is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check AFFX's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
CTEV vs NAVA Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas NAVA's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, CTEV is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for CTEV.Check NAVA's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
CTEV vs CHNGU Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas CHNGU's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, CTEV is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CHNGU's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
CTEV vs CHNG Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas CHNG's P/E ratio is -152.72. In terms of profitability, CTEV's ROE is +1.40%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, CTEV is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CHNG's competition here
Castlight Health, Inc. (NYSE: CSLT)
CTEV vs CSLT Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas CSLT's P/E ratio is -37.27. In terms of profitability, CTEV's ROE is +1.40%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, CTEV is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CSLT's competition here
NantHealth, Inc. (NASDAQ: NH)
CTEV vs NH Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, NH has a market cap of 0. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas NH's P/E ratio is -0.12. In terms of profitability, CTEV's ROE is +1.40%, compared to NH's ROE of +0.35%. Regarding short-term risk, CTEV is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check NH's competition here
CareCloud, Inc. (NASDAQ: MTBC)
CTEV vs MTBC Comparison August 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 596M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, CTEV is priced at $35.32 on the NYSE, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.06, whereas MTBC's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +1.40%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, CTEV is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check MTBC's competition here